Cargando…
IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism
BACKGROUND: Research evidence accumulated in the past years in both rodent and human models for autism spectrum disorders (ASD) have established insulin-like growth factor 1 (IGF-1) as one of the most promising ASD therapeutic interventions to date. ASD is phenotypically and etiologically heterogene...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320548/ https://www.ncbi.nlm.nih.gov/pubmed/32591005 http://dx.doi.org/10.1186/s13229-020-00359-w |